Acceleron Pharma Inc. – NASDAQ:XLRN
Acceleron Pharma stock price today
$178.75
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Acceleron Pharma stock price quarterly change
+2.62%
quarter
Acceleron Pharma stock price yearly change
+54.72%
year
Acceleron Pharma key metrics
Market Cap | N/A |
Enterprise value | 10.57B |
P/E | -42.74 |
EV/Sales | 93.79 |
EV/EBITDA | -42.20 |
Price/Sales | 96.59 |
Price/Book | 15.16 |
PEG ratio | 1.88 |
EPS | -4.21 |
Revenue | 112.76M |
EBITDA | -250.60M |
Income | -254.85M |
Revenue Q/Q | 51.58% |
Revenue Y/Y | 6.38% |
Profit margin | -226% |
Oper. margin | -226.57% |
Gross margin | 0% |
EBIT margin | -226.57% |
EBITDA margin | -222.24% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAcceleron Pharma stock price history
Acceleron Pharma stock forecast
Acceleron Pharma financial statements
| Dec 2020 | 25.86M | -57.39M | -221.89% |
|---|---|---|---|
| Mar 2021 | 24.75M | -63.47M | -256.37% |
| Jun 2021 | 27.94M | -63.52M | -227.35% |
| Sep 2021 | 34.19M | -70.46M | -206.04% |
| 2021-02-25 | -0.59 | -0.95 |
|---|---|---|
| 2021-05-06 | -0.81 | -1.05 |
| 2021-08-05 | -0.92 | -1.05 |
| 2021-11-04 | -1.15 | -1.14 |
| Dec 2020 | 932337000 | 77.23M | 8.28% |
|---|---|---|---|
| Mar 2021 | 875793000 | 64.96M | 7.42% |
| Jun 2021 | 836052000 | 73.01M | 8.73% |
| Sep 2021 | 787848000 | 69.69M | 8.85% |
| Dec 2020 | -38.13M | -29.6M | 8.99M |
|---|---|---|---|
| Mar 2021 | -67.92M | -151.21M | 3.69M |
| Jun 2021 | -84.41M | -37.13M | 2.23M |
| Sep 2021 | -70.88M | 56.79M | 14.15M |
Acceleron Pharma alternative data
| Aug 2023 | 312 |
|---|---|
| Sep 2023 | 312 |
| Oct 2023 | 312 |
| Nov 2023 | 312 |
| Dec 2023 | 312 |
| Jan 2024 | 312 |
| Feb 2024 | 312 |
| Mar 2024 | 312 |
| Apr 2024 | 312 |
| May 2024 | 312 |
| Jun 2024 | 312 |
| Jul 2024 | 312 |
Acceleron Pharma other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Oct 2020 | 0 | 75000 |
| Dec 2020 | 0 | 50000 |
| Jan 2021 | 0 | 27407 |
| Mar 2021 | 0 | 10000 |
| Apr 2021 | 0 | 86578 |
| Jul 2021 | 0 | 200000 |
| Sep 2021 | 0 | 43063 |
| Patent |
|---|
Grant Filling date: 5 Oct 2017 Issue date: 13 Sep 2022 |
Application Filling date: 19 Jan 2022 Issue date: 8 Sep 2022 |
Application Filling date: 4 Oct 2017 Issue date: 18 Aug 2022 |
Application Filling date: 8 Feb 2022 Issue date: 4 Aug 2022 |
Application Filling date: 29 May 2020 Issue date: 4 Aug 2022 |
Application Filling date: 16 Aug 2021 Issue date: 28 Jul 2022 |
Application Filling date: 24 Aug 2021 Issue date: 7 Jul 2022 |
Application Filling date: 8 Feb 2019 Issue date: 7 Jul 2022 |
Application Filling date: 5 Aug 2021 Issue date: 30 Jun 2022 |
Application Filling date: 25 Jun 2021 Issue date: 2 Jun 2022 |
| Quarter | Transcript |
|---|---|
| Q2 2021 8 Aug 2021 | Q2 2021 Earnings Call Transcript |
| Q1 2021 9 May 2021 | Q1 2021 Earnings Call Transcript |
| Q4 2020 25 Feb 2021 | Q4 2020 Earnings Call Transcript |
| Q2 2020 8 Aug 2020 | Q2 2020 Earnings Call Transcript |
-
What's the price of Acceleron Pharma stock today?
One share of Acceleron Pharma stock can currently be purchased for approximately $178.75.
-
When is Acceleron Pharma's next earnings date?
Unfortunately, Acceleron Pharma's (XLRN) next earnings date is currently unknown.
-
Does Acceleron Pharma pay dividends?
No, Acceleron Pharma does not pay dividends.
-
What is Acceleron Pharma's stock symbol?
Acceleron Pharma Inc. is traded on the NASDAQ under the ticker symbol "XLRN".
-
What is Acceleron Pharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Acceleron Pharma?
Shares of Acceleron Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Acceleron Pharma have?
As Jul 2024, Acceleron Pharma employs 312 workers.
-
When Acceleron Pharma went public?
Acceleron Pharma Inc. is publicly traded company for more then 11 years since IPO on 18 Sep 2013.
-
What is Acceleron Pharma's official website?
The official website for Acceleron Pharma is acceleronpharma.com.
-
Where are Acceleron Pharma's headquarters?
Acceleron Pharma is headquartered at 128 Sidney St, Cambridge, MASSACHUSETTS.
-
How can i contact Acceleron Pharma?
Acceleron Pharma's mailing address is 128 Sidney St, Cambridge, MASSACHUSETTS and company can be reached via phone at +1 617 649 9200.
Acceleron Pharma company profile:
Acceleron Pharma Inc.
acceleronpharma.comExchange:
NASDAQ
Full time employees:
312
Industry:
Biotechnology
Sector:
Healthcare
Acceleron Pharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. It offers luspatercept-aamt for the treatment of anemia in adult patients with beta-thalassemia under the REBLOZYL name. The company also develops luspatercept-aamt for the treatment of myelodysplastic syndromes and myelofibrosis; Sotatercept for the treatment of patients with pulmonary arterial hypertension; and ACE-083, a neuromuscular candidate that is in Phase II clinical trials for the treatment of patients with Charcot-Marie-Tooth disease. In addition, it has a collaboration, license, and option agreement with Celgene Corporation; and collaboration and license agreement with Fulcrum Therapeutics, Inc. to identify small molecules designed to modulate specific pathways associated with a targeted indication within the pulmonary disease space. The company was formerly known as Phoenix Pharma, Inc. Acceleron Pharma Inc. was founded in 2003 and is headquartered in Cambridge, Massachusetts.
128 Sidney St
Cambridge, MASSACHUSETTS 02139
Cambridge, MASSACHUSETTS 02139
CIK: 0001280600
ISIN: US00434H1086
CUSIP: 00434H108
